Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Shanghai Junshi Biosciences Co., Ltd.

http://junshipharma.com/en/Index.html

Latest From Shanghai Junshi Biosciences Co., Ltd.

Homegrown China Oral Antiviral Shows Early Promise

Junshi’s oral antiviral shows signs of effectiveness in treating patients with mild COVID-19 symptoms but more data are needed, caution researchers.

China Coronavirus COVID-19

Going Global Gets Stuck, Chinese Drug Makers CRL Show What Not To Do

Chinese drug makers have more to lament and plenty to learn from as Junshi, HutchMed follow Innovent Bio with FDA rejections. A holistic not opportunistic approach is needed, one ex-FDA expert suggests.

Drug Review Regulation

China’s Home-Grown Oral COVID Antiviral Eyes Wider Population

Simcere is weighing options for SIM0417 in a Phase I trial in China as the first major domestically-developed potential rival to Pfizer’s oral COVID-19 antiviral Paxlovid. The study is likely to include wider patient groups ranging from those without symptoms to severe patients.

China Clinical Trials

Kintor Soars On COVID Antiviral Data But Results' Significance Still Unclear

Chinese firm Kintor disclosed findings from a pivotal Phase III trial showing its androgen receptor antagonist proxalutamide achieved a 50% reduction in risk of hospitalization or death in COVID-19 patients with mild-to-moderate infection, although uncertainty remains over it being “unable to provide” a p-value in some data analyses.

China Clinical Trials
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Other Names / Subsidiaries
    • Junshi Biosciences
UsernamePublicRestriction

Register